Codagenix

Last updated: April 19, 2024

Founders: J. Robert Coleman, Eckard Wimmer, Steffen Mueller
Founders: J. Robert Coleman, Eckard Wimmer, Steffen Mueller
Country: USA | Funding: $65.6M (+)

Website: http://codagenix.com/

Codagenix employs a proprietary technology platform for the construction of live attenuated viral vaccines for flu and other targets.